Towards a Göttingen minipig model of adult onset growth hormone deficiency: evaluation of stereotactic electrocoagulation method
Laura Hvidsten Ørstrup,
Laura Tvilling,
Dariusz Orlowski,
Hamed Zaer,
Carsten Reidies Bjarkam,
Pia von Voss,
Pia Skårup Andersen,
Berit Ø. Christoffersen,
Jens Christian Hedemann Sørensen,
Torben Laursen,
Peter Thygesen,
Jens Lykkesfeldt,
Andreas Nørgaard Glud
Affiliations
Laura Hvidsten Ørstrup
Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark; Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
Laura Tvilling
CENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark
Dariusz Orlowski
CENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark
Hamed Zaer
CENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark
Carsten Reidies Bjarkam
Department of Neurosurgery, Aalborg University Hospital, Denmark; Clinical Institute, Aalborg University, Denmark
Pia von Voss
Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark
Pia Skårup Andersen
Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark
Berit Ø. Christoffersen
Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark
Jens Christian Hedemann Sørensen
CENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark
Torben Laursen
Department of Clinical Pharmacology, Aarhus University Hospital, Denmark
Peter Thygesen
Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark
Jens Lykkesfeldt
Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
Andreas Nørgaard Glud
CENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark; Corresponding author.
Background: Adult onset growth hormone (GH) deficiency (AGDH) is a potentially underdiagnosed condition, caused by damage to the pituitary gland. AGHD is treated with growth hormone replacement therapy. A large variety of clinical symptoms and changes in the metabolic homeostasis can be observed and quantified. New large animal models are needed for future drug development. New method: In this study, we evaluate methods for a new large non-primate animal model of GH deficiency in post pubertal Göttingen Minipigs (minipig). Lesions in the pituitary gland were made by stereotaxic monopolar thermo-coagulation guided by magnetic resonance imaging (MRI), and pituitary function was evaluated using insulin tolerance test (ITT) with measurements of growth hormone secretion induced by hypoglycemia. Results: Lesions were successfully applied to the pituitary gland without any damage to surrounding tissue including the hypothalamus, which was confirmed by post-operative MRI and post mortem histology. Plasma levels of GH during ITT showed no decrease in secreted levels one week after surgery compared to levels obtained before surgery. Comparison with existing methods: Compared to other GH insufficiency models, eloquent brain tissue is spared. Furthermore, alternatively to rodent models, a large animal model would allow the use of human intended equipment to evaluate disease. Using the minipig avoids social, economical and ethical issues, compared with primates. Conclusion: The lesions did not remove all GH production, but proof of concept is demonstrated. In addition, the ITT is presented as a safe and efficient method to diagnose GH deficiency in minipigs.